Amundi Index Solutions - Amundi MSCI USA SRI UCITS ETF DR
Amundi Index Solutions - Amundi MSCI USA SRI UCITS ETF DR (USRI.PA) Stock Competitors & Peer Comparison
See (USRI.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Asset Management Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| USRI.PA | €102.05 | +0.21% | 2.1B | N/A | N/A | N/A |
| CSPX.AS | €628.52 | +0.58% | 113.1B | N/A | N/A | N/A |
| IWDA.AS | €112.94 | +0.82% | 109.8B | N/A | N/A | N/A |
| VUSA.AS | €111.16 | +0.59% | 68.4B | N/A | N/A | +0.98% |
| VWRL.AS | €144.80 | +1.02% | 48.3B | N/A | N/A | +1.41% |
| SP5H.PA | €330.50 | +0.98% | 23.8B | 26.98 | €12.07 | +1.02% |
| SP5C.PA | €423.65 | +0.60% | 23.8B | 27.71 | €15.14 | N/A |
| IUSA.AS | €58.41 | +0.62% | 17.4B | N/A | N/A | +0.96% |
| ISFA.AS | €11.77 | +1.40% | 16.7B | N/A | N/A | +2.93% |
| CSH2.PA | €108.58 | +0.00% | 15.9B | 28.24 | €3.84 | N/A |
Stock Comparison
USRI.PA vs CSPX.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, CSPX.AS has a market cap of 113.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while CSPX.AS trades at €628.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas CSPX.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to CSPX.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to CSPX.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check CSPX.AS's competition here
USRI.PA vs IWDA.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, IWDA.AS has a market cap of 109.8B. Regarding current trading prices, USRI.PA is priced at €102.05, while IWDA.AS trades at €112.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas IWDA.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to IWDA.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to IWDA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check IWDA.AS's competition here
USRI.PA vs VUSA.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, VUSA.AS has a market cap of 68.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while VUSA.AS trades at €111.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas VUSA.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to VUSA.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to VUSA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check VUSA.AS's competition here
USRI.PA vs VWRL.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, VWRL.AS has a market cap of 48.3B. Regarding current trading prices, USRI.PA is priced at €102.05, while VWRL.AS trades at €144.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas VWRL.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to VWRL.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to VWRL.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check VWRL.AS's competition here
USRI.PA vs SP5H.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, SP5H.PA has a market cap of 23.8B. Regarding current trading prices, USRI.PA is priced at €102.05, while SP5H.PA trades at €330.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas SP5H.PA's P/E ratio is 26.98. In terms of profitability, USRI.PA's ROE is +0.00%, compared to SP5H.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to SP5H.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check SP5H.PA's competition here
USRI.PA vs SP5C.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, SP5C.PA has a market cap of 23.8B. Regarding current trading prices, USRI.PA is priced at €102.05, while SP5C.PA trades at €423.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas SP5C.PA's P/E ratio is 27.71. In terms of profitability, USRI.PA's ROE is +0.00%, compared to SP5C.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to SP5C.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check SP5C.PA's competition here
USRI.PA vs IUSA.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, IUSA.AS has a market cap of 17.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while IUSA.AS trades at €58.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas IUSA.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to IUSA.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to IUSA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check IUSA.AS's competition here
USRI.PA vs ISFA.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, ISFA.AS has a market cap of 16.7B. Regarding current trading prices, USRI.PA is priced at €102.05, while ISFA.AS trades at €11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas ISFA.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to ISFA.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to ISFA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check ISFA.AS's competition here
USRI.PA vs CSH2.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, CSH2.PA has a market cap of 15.9B. Regarding current trading prices, USRI.PA is priced at €102.05, while CSH2.PA trades at €108.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas CSH2.PA's P/E ratio is 28.24. In terms of profitability, USRI.PA's ROE is +0.00%, compared to CSH2.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to CSH2.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check CSH2.PA's competition here
USRI.PA vs HAL.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, HAL.AS has a market cap of 15.3B. Regarding current trading prices, USRI.PA is priced at €102.05, while HAL.AS trades at €172.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas HAL.AS's P/E ratio is 8.89. In terms of profitability, USRI.PA's ROE is +0.00%, compared to HAL.AS's ROE of +0.12%. Regarding short-term risk, USRI.PA is less volatile compared to HAL.AS. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check HAL.AS's competition here
USRI.PA vs AMUN.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, AMUN.PA has a market cap of 15.2B. Regarding current trading prices, USRI.PA is priced at €102.05, while AMUN.PA trades at €75.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas AMUN.PA's P/E ratio is 9.10. In terms of profitability, USRI.PA's ROE is +0.00%, compared to AMUN.PA's ROE of +0.13%. Regarding short-term risk, USRI.PA is less volatile compared to AMUN.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check AMUN.PA's competition here
USRI.PA vs MEUD.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, MEUD.PA has a market cap of 14.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while MEUD.PA trades at €292.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas MEUD.PA's P/E ratio is 18.18. In terms of profitability, USRI.PA's ROE is +0.00%, compared to MEUD.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to MEUD.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check MEUD.PA's competition here
USRI.PA vs I500.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, I500.AS has a market cap of 13.2B. Regarding current trading prices, USRI.PA is priced at €102.05, while I500.AS trades at €11.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas I500.AS's P/E ratio is 27.03. In terms of profitability, USRI.PA's ROE is +0.00%, compared to I500.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to I500.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check I500.AS's competition here
USRI.PA vs I50D.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, I50D.AS has a market cap of 13.2B. Regarding current trading prices, USRI.PA is priced at €102.05, while I50D.AS trades at €7.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas I50D.AS's P/E ratio is 27.04. In terms of profitability, USRI.PA's ROE is +0.00%, compared to I50D.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to I50D.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check I50D.AS's competition here
USRI.PA vs GOLD.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, GOLD.PA has a market cap of 12B. Regarding current trading prices, USRI.PA is priced at €102.05, while GOLD.PA trades at €176.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas GOLD.PA's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to GOLD.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to GOLD.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check GOLD.PA's competition here
USRI.PA vs IMEU.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, IMEU.AS has a market cap of 10.5B. Regarding current trading prices, USRI.PA is priced at €102.05, while IMEU.AS trades at €37.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas IMEU.AS's P/E ratio is 18.84. In terms of profitability, USRI.PA's ROE is +0.00%, compared to IMEU.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to IMEU.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check IMEU.AS's competition here
USRI.PA vs GBLB.BR Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, GBLB.BR has a market cap of 9.7B. Regarding current trading prices, USRI.PA is priced at €102.05, while GBLB.BR trades at €81.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas GBLB.BR's P/E ratio is 79.60. In terms of profitability, USRI.PA's ROE is +0.00%, compared to GBLB.BR's ROE of -0.01%. Regarding short-term risk, USRI.PA is less volatile compared to GBLB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check GBLB.BR's competition here
USRI.PA vs PSH.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, PSH.AS has a market cap of 9.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while PSH.AS trades at €51.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas PSH.AS's P/E ratio is 4.41. In terms of profitability, USRI.PA's ROE is +0.00%, compared to PSH.AS's ROE of +0.09%. Regarding short-term risk, USRI.PA is less volatile compared to PSH.AS. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check PSH.AS's competition here
USRI.PA vs WLDHC.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, WLDHC.PA has a market cap of 9.3B. Regarding current trading prices, USRI.PA is priced at €102.05, while WLDHC.PA trades at €15.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas WLDHC.PA's P/E ratio is 24.05. In terms of profitability, USRI.PA's ROE is +0.00%, compared to WLDHC.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to WLDHC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check WLDHC.PA's competition here
USRI.PA vs WLDH.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, WLDH.PA has a market cap of 9.3B. Regarding current trading prices, USRI.PA is priced at €102.05, while WLDH.PA trades at €240.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas WLDH.PA's P/E ratio is 24.02. In terms of profitability, USRI.PA's ROE is +0.00%, compared to WLDH.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to WLDH.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check WLDH.PA's competition here
USRI.PA vs WLD.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, WLD.PA has a market cap of 9.3B. Regarding current trading prices, USRI.PA is priced at €102.05, while WLD.PA trades at €380.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas WLD.PA's P/E ratio is 24.51. In terms of profitability, USRI.PA's ROE is +0.00%, compared to WLD.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to WLD.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check WLD.PA's competition here
USRI.PA vs CBUG.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, CBUG.AS has a market cap of 8.9B. Regarding current trading prices, USRI.PA is priced at €102.05, while CBUG.AS trades at €4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas CBUG.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to CBUG.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to CBUG.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check CBUG.AS's competition here
USRI.PA vs VHYL.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, VHYL.AS has a market cap of 8.7B. Regarding current trading prices, USRI.PA is priced at €102.05, while VHYL.AS trades at €74.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas VHYL.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to VHYL.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to VHYL.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check VHYL.AS's competition here
USRI.PA vs CEUU.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, CEUU.AS has a market cap of 8.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while CEUU.AS trades at €11.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas CEUU.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to CEUU.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to CEUU.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check CEUU.AS's competition here
USRI.PA vs SOF.BR Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, SOF.BR has a market cap of 8.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while SOF.BR trades at €241.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas SOF.BR's P/E ratio is 20.00. In terms of profitability, USRI.PA's ROE is +0.00%, compared to SOF.BR's ROE of +0.04%. Regarding short-term risk, USRI.PA is less volatile compared to SOF.BR. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check SOF.BR's competition here
USRI.PA vs PHAU.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, PHAU.AS has a market cap of 7.7B. Regarding current trading prices, USRI.PA is priced at €102.05, while PHAU.AS trades at €413.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas PHAU.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to PHAU.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to PHAU.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check PHAU.AS's competition here
USRI.PA vs AEME.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, AEME.PA has a market cap of 7.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while AEME.PA trades at €87.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas AEME.PA's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to AEME.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to AEME.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check AEME.PA's competition here
USRI.PA vs SJPD.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, SJPD.AS has a market cap of 7.5B. Regarding current trading prices, USRI.PA is priced at €102.05, while SJPD.AS trades at €8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas SJPD.AS's P/E ratio is 17.19. In terms of profitability, USRI.PA's ROE is +0.00%, compared to SJPD.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to SJPD.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check SJPD.AS's competition here
USRI.PA vs IWRD.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, IWRD.AS has a market cap of 7.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while IWRD.AS trades at €81.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas IWRD.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to IWRD.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to IWRD.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check IWRD.AS's competition here
USRI.PA vs IEMM.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, IEMM.AS has a market cap of 7.3B. Regarding current trading prices, USRI.PA is priced at €102.05, while IEMM.AS trades at €50.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas IEMM.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to IEMM.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to IEMM.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check IEMM.AS's competition here
USRI.PA vs LCWD.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, LCWD.PA has a market cap of 7B. Regarding current trading prices, USRI.PA is priced at €102.05, while LCWD.PA trades at €19.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas LCWD.PA's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to LCWD.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to LCWD.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check LCWD.PA's competition here
USRI.PA vs SJPE.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, SJPE.AS has a market cap of 6.7B. Regarding current trading prices, USRI.PA is priced at €102.05, while SJPE.AS trades at €13.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas SJPE.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to SJPE.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to SJPE.AS. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check SJPE.AS's competition here
USRI.PA vs VEUR.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, VEUR.AS has a market cap of 6.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while VEUR.AS trades at €46.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas VEUR.AS's P/E ratio is 18.56. In terms of profitability, USRI.PA's ROE is +0.00%, compared to VEUR.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to VEUR.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check VEUR.AS's competition here
USRI.PA vs ECRP.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, ECRP.PA has a market cap of 6.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while ECRP.PA trades at €54.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas ECRP.PA's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to ECRP.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to ECRP.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check ECRP.PA's competition here
USRI.PA vs CC4.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, CC4.PA has a market cap of 6.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while CC4.PA trades at €227.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas CC4.PA's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to CC4.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to CC4.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check CC4.PA's competition here
USRI.PA vs IJPA.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, IJPA.AS has a market cap of 6.5B. Regarding current trading prices, USRI.PA is priced at €102.05, while IJPA.AS trades at €64.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas IJPA.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to IJPA.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to IJPA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check IJPA.AS's competition here
USRI.PA vs IEMA.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, IEMA.AS has a market cap of 6.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while IEMA.AS trades at €48.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas IEMA.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to IEMA.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to IEMA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check IEMA.AS's competition here
USRI.PA vs CW8.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, CW8.PA has a market cap of 5.9B. Regarding current trading prices, USRI.PA is priced at €102.05, while CW8.PA trades at €615.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas CW8.PA's P/E ratio is 24.53. In terms of profitability, USRI.PA's ROE is +0.00%, compared to CW8.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to CW8.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check CW8.PA's competition here
USRI.PA vs EWLD.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, EWLD.PA has a market cap of 5.8B. Regarding current trading prices, USRI.PA is priced at €102.05, while EWLD.PA trades at €36.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas EWLD.PA's P/E ratio is 24.55. In terms of profitability, USRI.PA's ROE is +0.00%, compared to EWLD.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to EWLD.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check EWLD.PA's competition here
USRI.PA vs 500.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, 500.PA has a market cap of 5.7B. Regarding current trading prices, USRI.PA is priced at €102.05, while 500.PA trades at €116.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas 500.PA's P/E ratio is 27.69. In terms of profitability, USRI.PA's ROE is +0.00%, compared to 500.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to 500.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check 500.PA's competition here
USRI.PA vs AUEM.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, AUEM.PA has a market cap of 5.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while AUEM.PA trades at €7.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas AUEM.PA's P/E ratio is 16.98. In terms of profitability, USRI.PA's ROE is +0.00%, compared to AUEM.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to AUEM.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check AUEM.PA's competition here
USRI.PA vs TDIV.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, TDIV.AS has a market cap of 5.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while TDIV.AS trades at €51.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas TDIV.AS's P/E ratio is 14.79. In terms of profitability, USRI.PA's ROE is +0.00%, compared to TDIV.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to TDIV.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check TDIV.AS's competition here
USRI.PA vs KBCA.BR Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, KBCA.BR has a market cap of 5.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while KBCA.BR trades at €74.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas KBCA.BR's P/E ratio is 17.71. In terms of profitability, USRI.PA's ROE is +0.00%, compared to KBCA.BR's ROE of +0.09%. Regarding short-term risk, USRI.PA is less volatile compared to KBCA.BR. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check KBCA.BR's competition here
USRI.PA vs UST.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, UST.PA has a market cap of 5.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while UST.PA trades at €87.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas UST.PA's P/E ratio is 32.92. In terms of profitability, USRI.PA's ROE is +0.00%, compared to UST.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to UST.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check UST.PA's competition here
USRI.PA vs EUEA.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, EUEA.AS has a market cap of 5.3B. Regarding current trading prices, USRI.PA is priced at €102.05, while EUEA.AS trades at €59.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas EUEA.AS's P/E ratio is 18.28. In terms of profitability, USRI.PA's ROE is +0.00%, compared to EUEA.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to EUEA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check EUEA.AS's competition here
USRI.PA vs USA.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, USA.PA has a market cap of 5.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while USA.PA trades at €534.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas USA.PA's P/E ratio is 27.49. In terms of profitability, USRI.PA's ROE is +0.00%, compared to USA.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to USA.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check USA.PA's competition here
USRI.PA vs S500.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, S500.PA has a market cap of 5.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while S500.PA trades at €170.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas S500.PA's P/E ratio is 27.95. In terms of profitability, USRI.PA's ROE is +0.00%, compared to S500.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to S500.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check S500.PA's competition here
USRI.PA vs ALLFG.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, ALLFG.AS has a market cap of 5.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while ALLFG.AS trades at €8.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas ALLFG.AS's P/E ratio is -32.21. In terms of profitability, USRI.PA's ROE is +0.00%, compared to ALLFG.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to ALLFG.AS. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check ALLFG.AS's competition here
USRI.PA vs REINA.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, REINA.AS has a market cap of 5.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while REINA.AS trades at €28.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas REINA.AS's P/E ratio is 37.84. In terms of profitability, USRI.PA's ROE is +0.00%, compared to REINA.AS's ROE of +0.02%. Regarding short-term risk, USRI.PA is more volatile compared to REINA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check REINA.AS's competition here
USRI.PA vs C50U.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, C50U.PA has a market cap of 5.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while C50U.PA trades at €178.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas C50U.PA's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to C50U.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to C50U.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check C50U.PA's competition here
USRI.PA vs USAC.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, USAC.PA has a market cap of 5B. Regarding current trading prices, USRI.PA is priced at €102.05, while USAC.PA trades at €584.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas USAC.PA's P/E ratio is 27.77. In terms of profitability, USRI.PA's ROE is +0.00%, compared to USAC.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to USAC.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check USAC.PA's competition here
USRI.PA vs S500H.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, S500H.PA has a market cap of 5B. Regarding current trading prices, USRI.PA is priced at €102.05, while S500H.PA trades at €96.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas S500H.PA's P/E ratio is 27.17. In terms of profitability, USRI.PA's ROE is +0.00%, compared to S500H.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to S500H.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check S500H.PA's competition here
USRI.PA vs AEEM.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, AEEM.PA has a market cap of 4.9B. Regarding current trading prices, USRI.PA is priced at €102.05, while AEEM.PA trades at €6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas AEEM.PA's P/E ratio is 17.15. In terms of profitability, USRI.PA's ROE is +0.00%, compared to AEEM.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to AEEM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check AEEM.PA's competition here
USRI.PA vs EXCH.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, EXCH.AS has a market cap of 4.7B. Regarding current trading prices, USRI.PA is priced at €102.05, while EXCH.AS trades at €7.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas EXCH.AS's P/E ratio is 18.69. In terms of profitability, USRI.PA's ROE is +0.00%, compared to EXCH.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to EXCH.AS. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check EXCH.AS's competition here
USRI.PA vs ICHD.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, ICHD.AS has a market cap of 4.5B. Regarding current trading prices, USRI.PA is priced at €102.05, while ICHD.AS trades at €5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas ICHD.AS's P/E ratio is 12.89. In terms of profitability, USRI.PA's ROE is +0.00%, compared to ICHD.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to ICHD.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check ICHD.AS's competition here
USRI.PA vs ICHN.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, ICHN.AS has a market cap of 4.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while ICHN.AS trades at €5.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas ICHN.AS's P/E ratio is 12.89. In terms of profitability, USRI.PA's ROE is +0.00%, compared to ICHN.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to ICHN.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check ICHN.AS's competition here
USRI.PA vs VERX.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, VERX.AS has a market cap of 4.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while VERX.AS trades at €46.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas VERX.AS's P/E ratio is 18.15. In terms of profitability, USRI.PA's ROE is +0.00%, compared to VERX.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to VERX.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check VERX.AS's competition here
USRI.PA vs C50.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, C50.PA has a market cap of 4.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while C50.PA trades at €153.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas C50.PA's P/E ratio is 18.08. In terms of profitability, USRI.PA's ROE is +0.00%, compared to C50.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to C50.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check C50.PA's competition here
USRI.PA vs CD5.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, CD5.PA has a market cap of 4.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while CD5.PA trades at €92.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas CD5.PA's P/E ratio is 18.07. In terms of profitability, USRI.PA's ROE is +0.00%, compared to CD5.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to CD5.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check CD5.PA's competition here
USRI.PA vs SEMD.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, SEMD.AS has a market cap of 4.2B. Regarding current trading prices, USRI.PA is priced at €102.05, while SEMD.AS trades at €6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas SEMD.AS's P/E ratio is 17.01. In terms of profitability, USRI.PA's ROE is +0.00%, compared to SEMD.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to SEMD.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check SEMD.AS's competition here
USRI.PA vs MSE.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, MSE.PA has a market cap of 4.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while MSE.PA trades at €65.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas MSE.PA's P/E ratio is 17.62. In terms of profitability, USRI.PA's ROE is +0.00%, compared to MSE.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to MSE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check MSE.PA's competition here
USRI.PA vs CACC.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, CACC.PA has a market cap of 4.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while CACC.PA trades at €39.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas CACC.PA's P/E ratio is 18.42. In terms of profitability, USRI.PA's ROE is +0.00%, compared to CACC.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to CACC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check CACC.PA's competition here
USRI.PA vs CAC.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, CAC.PA has a market cap of 4.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while CAC.PA trades at €79.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas CAC.PA's P/E ratio is 18.40. In terms of profitability, USRI.PA's ROE is +0.00%, compared to CAC.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to CAC.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check CAC.PA's competition here
USRI.PA vs 500X.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, 500X.AS has a market cap of 4B. Regarding current trading prices, USRI.PA is priced at €102.05, while 500X.AS trades at €42.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas 500X.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to 500X.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to 500X.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check 500X.AS's competition here
USRI.PA vs WSRI.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, WSRI.PA has a market cap of 4B. Regarding current trading prices, USRI.PA is priced at €102.05, while WSRI.PA trades at €103.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas WSRI.PA's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to WSRI.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to WSRI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check WSRI.PA's competition here
USRI.PA vs AGGD.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, AGGD.AS has a market cap of 3.9B. Regarding current trading prices, USRI.PA is priced at €102.05, while AGGD.AS trades at €5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas AGGD.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to AGGD.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to AGGD.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check AGGD.AS's competition here
USRI.PA vs SRIL.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, SRIL.AS has a market cap of 3.8B. Regarding current trading prices, USRI.PA is priced at €102.05, while SRIL.AS trades at €12.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas SRIL.AS's P/E ratio is 24.74. In terms of profitability, USRI.PA's ROE is +0.00%, compared to SRIL.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to SRIL.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check SRIL.AS's competition here
USRI.PA vs GLUH.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, GLUH.AS has a market cap of 3.8B. Regarding current trading prices, USRI.PA is priced at €102.05, while GLUH.AS trades at €4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas GLUH.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to GLUH.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to GLUH.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check GLUH.AS's competition here
USRI.PA vs EHYA.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, EHYA.AS has a market cap of 3.7B. Regarding current trading prices, USRI.PA is priced at €102.05, while EHYA.AS trades at €5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas EHYA.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to EHYA.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to EHYA.AS. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check EHYA.AS's competition here
USRI.PA vs EHYD.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, EHYD.AS has a market cap of 3.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while EHYD.AS trades at €4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas EHYD.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to EHYD.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to EHYD.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check EHYD.AS's competition here
USRI.PA vs ROLA.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, ROLA.AS has a market cap of 3.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while ROLA.AS trades at €65.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas ROLA.AS's P/E ratio is 6.46. In terms of profitability, USRI.PA's ROE is +0.00%, compared to ROLA.AS's ROE of N/A. Regarding short-term risk, USRI.PA is more volatile compared to ROLA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check ROLA.AS's competition here
USRI.PA vs EEUE.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, EEUE.PA has a market cap of 3.5B. Regarding current trading prices, USRI.PA is priced at €102.05, while EEUE.PA trades at €18.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas EEUE.PA's P/E ratio is 18.85. In terms of profitability, USRI.PA's ROE is +0.00%, compared to EEUE.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to EEUE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check EEUE.PA's competition here
USRI.PA vs MF.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, MF.PA has a market cap of 3.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while MF.PA trades at €82.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas MF.PA's P/E ratio is -20.22. In terms of profitability, USRI.PA's ROE is +0.00%, compared to MF.PA's ROE of +0.19%. Regarding short-term risk, USRI.PA is less volatile compared to MF.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check MF.PA's competition here
USRI.PA vs WESE.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, WESE.PA has a market cap of 3.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while WESE.PA trades at €77.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas WESE.PA's P/E ratio is 24.68. In terms of profitability, USRI.PA's ROE is +0.00%, compared to WESE.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to WESE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check WESE.PA's competition here
USRI.PA vs GEMU.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, GEMU.PA has a market cap of 3.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while GEMU.PA trades at €9.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas GEMU.PA's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to GEMU.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to GEMU.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check GEMU.PA's competition here
USRI.PA vs IDSE.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, IDSE.AS has a market cap of 3.3B. Regarding current trading prices, USRI.PA is priced at €102.05, while IDSE.AS trades at €142.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas IDSE.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to IDSE.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to IDSE.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check IDSE.AS's competition here
USRI.PA vs ISED.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, ISED.AS has a market cap of 3.3B. Regarding current trading prices, USRI.PA is priced at €102.05, while ISED.AS trades at €7.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas ISED.AS's P/E ratio is 20.37. In terms of profitability, USRI.PA's ROE is +0.00%, compared to ISED.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to ISED.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check ISED.AS's competition here
USRI.PA vs PHAG.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, PHAG.AS has a market cap of 3.2B. Regarding current trading prices, USRI.PA is priced at €102.05, while PHAG.AS trades at €69.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas PHAG.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to PHAG.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to PHAG.AS. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check PHAG.AS's competition here
USRI.PA vs IMBE.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, IMBE.AS has a market cap of 3.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while IMBE.AS trades at €4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas IMBE.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to IMBE.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to IMBE.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check IMBE.AS's competition here
USRI.PA vs BNKE.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, BNKE.PA has a market cap of 3.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while BNKE.PA trades at €309.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas BNKE.PA's P/E ratio is 10.38. In terms of profitability, USRI.PA's ROE is +0.00%, compared to BNKE.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to BNKE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check BNKE.PA's competition here
USRI.PA vs BREB.BR Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, BREB.BR has a market cap of 3B. Regarding current trading prices, USRI.PA is priced at €102.05, while BREB.BR trades at €104.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas BREB.BR's P/E ratio is 60.58. In terms of profitability, USRI.PA's ROE is +0.00%, compared to BREB.BR's ROE of +0.01%. Regarding short-term risk, USRI.PA is less volatile compared to BREB.BR. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check BREB.BR's competition here
USRI.PA vs CB3.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, CB3.PA has a market cap of 3B. Regarding current trading prices, USRI.PA is priced at €102.05, while CB3.PA trades at €222.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas CB3.PA's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to CB3.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to CB3.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check CB3.PA's competition here
USRI.PA vs ESE.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, ESE.PA has a market cap of 2.9B. Regarding current trading prices, USRI.PA is priced at €102.05, while ESE.PA trades at €29.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas ESE.PA's P/E ratio is 27.73. In terms of profitability, USRI.PA's ROE is +0.00%, compared to ESE.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to ESE.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check ESE.PA's competition here
USRI.PA vs RF.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, RF.PA has a market cap of 2.9B. Regarding current trading prices, USRI.PA is priced at €102.05, while RF.PA trades at €45.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas RF.PA's P/E ratio is -5.03. In terms of profitability, USRI.PA's ROE is +0.00%, compared to RF.PA's ROE of -0.09%. Regarding short-term risk, USRI.PA is less volatile compared to RF.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check RF.PA's competition here
USRI.PA vs TKO.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, TKO.PA has a market cap of 2.9B. Regarding current trading prices, USRI.PA is priced at €102.05, while TKO.PA trades at €16.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas TKO.PA's P/E ratio is 16.27. In terms of profitability, USRI.PA's ROE is +0.00%, compared to TKO.PA's ROE of +0.03%. Regarding short-term risk, USRI.PA is less volatile compared to TKO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check TKO.PA's competition here
USRI.PA vs SGLU.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, SGLU.AS has a market cap of 2.8B. Regarding current trading prices, USRI.PA is priced at €102.05, while SGLU.AS trades at €5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas SGLU.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to SGLU.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to SGLU.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check SGLU.AS's competition here
USRI.PA vs SUOA.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, SUOA.AS has a market cap of 2.8B. Regarding current trading prices, USRI.PA is priced at €102.05, while SUOA.AS trades at €5.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas SUOA.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to SUOA.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to SUOA.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check SUOA.AS's competition here
USRI.PA vs TI5A.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, TI5A.AS has a market cap of 2.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while TI5A.AS trades at €116.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas TI5A.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to TI5A.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to TI5A.AS. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check TI5A.AS's competition here
USRI.PA vs EPAB.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, EPAB.PA has a market cap of 2.6B. Regarding current trading prices, USRI.PA is priced at €102.05, while EPAB.PA trades at €38.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas EPAB.PA's P/E ratio is 16.65. In terms of profitability, USRI.PA's ROE is +0.00%, compared to EPAB.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to EPAB.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check EPAB.PA's competition here
USRI.PA vs BNK.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, BNK.PA has a market cap of 2.5B. Regarding current trading prices, USRI.PA is priced at €102.05, while BNK.PA trades at €58.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas BNK.PA's P/E ratio is 11.24. In terms of profitability, USRI.PA's ROE is +0.00%, compared to BNK.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to BNK.PA. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check BNK.PA's competition here
USRI.PA vs JAPB.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, JAPB.AS has a market cap of 2.5B. Regarding current trading prices, USRI.PA is priced at €102.05, while JAPB.AS trades at €922.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas JAPB.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to JAPB.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to JAPB.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check JAPB.AS's competition here
USRI.PA vs TNOW.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, TNOW.PA has a market cap of 2.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while TNOW.PA trades at €929.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas TNOW.PA's P/E ratio is 35.43. In terms of profitability, USRI.PA's ROE is +0.00%, compared to TNOW.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to TNOW.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check TNOW.PA's competition here
USRI.PA vs IUHE.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, IUHE.AS has a market cap of 2.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while IUHE.AS trades at €7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas IUHE.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to IUHE.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to IUHE.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check IUHE.AS's competition here
USRI.PA vs ANX.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, ANX.PA has a market cap of 2.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while ANX.PA trades at €246.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas ANX.PA's P/E ratio is 32.91. In terms of profitability, USRI.PA's ROE is +0.00%, compared to ANX.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to ANX.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check ANX.PA's competition here
USRI.PA vs IGLE.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, IGLE.AS has a market cap of 2.4B. Regarding current trading prices, USRI.PA is priced at €102.05, while IGLE.AS trades at €4.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas IGLE.AS's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to IGLE.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to IGLE.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check IGLE.AS's competition here
USRI.PA vs SEMI.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, SEMI.AS has a market cap of 2.3B. Regarding current trading prices, USRI.PA is priced at €102.05, while SEMI.AS trades at €13.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas SEMI.AS's P/E ratio is 35.53. In terms of profitability, USRI.PA's ROE is +0.00%, compared to SEMI.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is less volatile compared to SEMI.AS. This indicates potentially lower risk in terms of short-term price fluctuations for USRI.PA.Check SEMI.AS's competition here
USRI.PA vs AASI.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, AASI.PA has a market cap of 2.2B. Regarding current trading prices, USRI.PA is priced at €102.05, while AASI.PA trades at €49.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas AASI.PA's P/E ratio is 18.21. In terms of profitability, USRI.PA's ROE is +0.00%, compared to AASI.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to AASI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check AASI.PA's competition here
USRI.PA vs ACWI.PA Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, ACWI.PA has a market cap of 2.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while ACWI.PA trades at €539.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas ACWI.PA's P/E ratio is N/A. In terms of profitability, USRI.PA's ROE is +0.00%, compared to ACWI.PA's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to ACWI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check ACWI.PA's competition here
USRI.PA vs CTEC.AS Comparison March 2026
USRI.PA plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, USRI.PA stands at 2.1B. In comparison, CTEC.AS has a market cap of 2.1B. Regarding current trading prices, USRI.PA is priced at €102.05, while CTEC.AS trades at €5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
USRI.PA currently has a P/E ratio of N/A, whereas CTEC.AS's P/E ratio is 16.86. In terms of profitability, USRI.PA's ROE is +0.00%, compared to CTEC.AS's ROE of +0.00%. Regarding short-term risk, USRI.PA is more volatile compared to CTEC.AS. This indicates potentially higher risk in terms of short-term price fluctuations for USRI.PA.Check CTEC.AS's competition here